Purchase Order 75N98026P01129
Award Date 7/30/26
Potential Completion Date 9/30/26
Potential Value $27K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The National Human Genome Research Institute awarded a purchase order to Twist Bioscience Corporation valued at $24,465.50 on September 4, 2020, for synthetic biology and DNA synthesis products. Performance is at Twist Bioscience's facility in South San Francisco, California, with a completion date of November 30, 2020. The order carries firm fixed-price pricing with no small business set-aside.</p>
- This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
- This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract is for the provision of biological and reagent materials, with a ceiling value of $12,206.25 and a period of performance through September 4, 2025. There is no set-aside designation for this...
- The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $77,874 purchase order to Twist Bioscience Corporation of South San Francisco, California. Under the firm fixed price contract, Twist Bioscience will provide custom cloned pooled oligo libraries in support of the NIH NIA's biomedical research efforts. The contract runs from July 10, 2023 through August 31, 2023 and represents a small purchase awarded directly to the prime contractor...
- <p>The civilian Headquarters Division of the Funding Federal Agency awarded a purchase order to Twist Bioscience Corporation for $97,120.00 firm fixed price on June 29, 2026, with ultimate completion by July 20, 2026. Work is performed in South San Francisco, California. The order covers Twist Bioscience equipment. No set-aside was used.</p>
- This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...
- This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Twist Bioscience Corporation. The $21,578.25 contract is for the delivery of oligonucleotide pools needed for a gene expression/MPRA (Massively Parallel Reporter Assay) research project. The contract has no set-aside designation and is scheduled for completion by September 30, 2024. Twist Bioscience is a synthetic biology company...
- This is a firm fixed price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS) to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the acquisition of Infinium MethylationEPIC BeadChip Kits (96 samples). The total ceiling value of the award is $77,552.64. The contract is sole-source as Illumina is the sole manufacturer and distributor of this product, which is needed to maintain consistency with existing lab equipment and project...
- The National Human Genome Research Institute issued a $58,874.11 delivery order to Illumina, Inc. on September 26, 2017, for Infinium methylation array services targeting over 830,000 methylated CpGs across promoter, gene body, and enhancer regions for genome-wide methylation studies on 96 samples using 12 beadchips. Place of performance is North Bethesda, MD. The order carries a firm fixed-price structure with an ultimate completion date of October 26, 2017. No set-aside was used.
- <p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $99,922.24 on July 16, 2026, for two sequencing reagent kits: Infinium MethylationEPIC v2.0 Kit (96 samples) and Infinium Global Diversity Array-8 v1.0 Kit (96 samples). No set-aside was used. Place of performance is Bethesda, Maryland. The order carries firm fixed price terms with an ultimate completion date of July 15, 2027.</p>